Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Evaluation of the Use of Clinical Decision Support and Online Resources for Pharmacogenomics Education
Vitek, Carolyn R. Rohrer , Nicholson, Wayne T. , Schultz, Cloann G. , Rohrer Vitek, Carolyn R, Schultz, Cloann, Caraballo, Pedro J.

Pharmacogenomics | September 30, 2015 | Volume: 16 | Issue: 14 | Pages: 1595-1603

10.2217/pgs.15.100 | PMID 26419532 Get It

Sex Steroid Hormone Levels May Not Explain Gender Differences in Development of Nephrolithiasis
Knoedler, John, Krambeck, Amy E. , Astorne, Walter, Bergstralh, Erik J., Knoedler, John Joseph, Bergstralh, Erik, Lieske, John, Lieske, John C.

Journal of Endourology | September 30, 2015 | Volume: 29 | Issue: 12 | Pages: 1341-1345

10.1089/end.2015.0255 | PMID 26422682 Get It

Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data
Elishmereni, Moran, Shukrun, Ilan, Bevan, Graham H. , Nandy, Debashis, McKenzie, Kyle, Kohli, Manish , Agur, Zvia , McKenzie, Kyle M, Kheifetz, Yuri , Kohli, Manish

The Prostate | September 30, 2015 | Volume: 76 | Issue: 1 | Pages: 48-57

10.1002/pros.23099 | PMID 26419619 Get It

BACKGROUNDProstate cancer (PCa) is a leading cause of cancer death of men worldwide. In hormone‐sensitive prostate cancer (HSPC), androgen deprivation therapy (ADT) is widely used, but an eventual failure on ADT heralds the passage to the castration‐resistant prostate cancer (CRPC) stage. Because predicting time to failure on ADT would allow improved planning of personal treatment strategy, we aimed to develop a predictive personalization algorithm for ADT efficacy in HSPC patients.METHODSA mathematical mechanistic model for HSPC progression and treatment was developed based on the underlying disease dynamics (represented by prostate‐specific antigen; PSA) as affected by ADT. Following fine‐tuning by a dataset of ADT‐treated HSPC patients, the model was embedded in an algorithm, which predicts the patient's time to biochemical failure (BF) based on clinical metrics obtained before or early in‐treatment.RESULTSThe mechanistic model, including a tumor growth law with a dynamic power and an elaborate ADT‐resistance mechanism, successfully retrieved individual time‐courses of PSA (R2 = 0.783). Using the personal Gleason score (GS) and PSA at diagnosis, as well as PSA dynamics from 6 months after ADT onset, and given the full ADT regimen, the personalization algorithm accurately predicted the individual time to BF of ADT in 90% of patients in the retrospective cohort (R2 = 0.98).CONCLUSIONSThe algorithm we have developed, predicting biochemical failure based on routine clinical tests, could be especially useful for patients destined for short‐lived ADT responses and quick progression to CRPC. Prospective studies must validate the utility of the algorithm for clinical decision‐making. Prostate 76:48–57, 2016. © 2015 Wiley Periodicals, Inc.
Analyzing the Potential for Incorrect Haplotype Calls with Different Pharmacogenomic Assays in Different Populations: A Simulation Based on 1000 Genomes Data
Samwald, Matthias , Blagec, Kathrin , Freimuth, Robert R. , Hofer, Sebastian J. , Freimuth, Robert R

Pharmacogenomics | September 30, 2015 | Volume: 16 | Issue: 15 | Pages: 1713-1721

10.2217/pgs.15.108 | PMID 26419264 Get It

Palliative Radiation for Leukemic Arthropathy from Human T-Cell Lymphoma Virus-associated Adult T-Cell Leukemia Lymphoma
Birckhead, Brandon , Peterson, Jennifer , Patel, Ajay , Miller, Robert C. , Birckhead, Brandon J, Peterson, Jennifer L., Patel, Ajay B

Rare Tumors | September 30, 2015 | Volume: 7 | Issue: 3 | Pages: 102-104

10.4081/rt.2015.5834 | PMID 26500728 Get It

Human T-cell lymphoma virus (HTLV)-associated adult T-cell leukemia lymphoma is a rare cancer in the United States, but there are several areas around the world where the virus is endemic. HTLV-associated adult T-cell leukemia lymphoma has been associated with leukemic arthropathy. We present a patient with HTLV-associated adult T-cell leukemia lymphoma with leukemic arthropathy. Although non-steroidal anti-inflammatory drugs and chemotherapy are often used for treatment, we describe the successful use of radiation therapy in the palliative relief of symptoms from leukemic arthropathy.
Recurrent duplications of 17q12 associated with variable phenotypes
Mitchell, Elyse, Douglas, Andrew G. L. , Kjaegaard, Susanne, Callewaert, Bert , Janssens, Sandra , Yuen, Amy Lawson, Skinner, Cindy , Failla, Pinella , Alberti, A , Avola, Emanuela , Fichera, Marco , Kibæk, Maria, Digilio, M. Cristina , Hannibal, Mark , Hollander, Nicolette S. den , Bizzarri, Veronica, Renieri, Alessandra , Mencarelli, Maria Antonietta , Fitzgerald, Tomas , Piazzolla, Serena, Oudenhove, Elke Van , Romano, Corrado , Schwartz, Charles E. , Rajan, Diana, Crolla, John A., Carter, Nigel, Hodge, Jennelle C. , Vanlander, Arnaud Vincent , Eichler, Evan E , Slavotinek, Anne , Escobar, Luis Fernando , Mefford, Heather C. , Callewaert, Bert , Renieri, Alessandra

American Journal of Medical Genetics Part A | September 30, 2015 | Volume: 167 | Issue: 12 | Pages: 3038-3045

10.1002/ajmg.a.37351 | PMID 26420380 Get It

The ability to identify the clinical nature of the recurrent duplication of chromosome 17q12 has been limited by its rarity and the diverse range of phenotypes associated with this genomic change. In order to further define the clinical features of affected patients, detailed clinical information was collected in the largest series to date (30 patients and 2 of their siblings) through a multi‐institutional collaborative effort. The majority of patients presented with developmental delays varying from mild to severe. Though dysmorphic features were commonly reported, patients do not have consistent and recognizable features. Cardiac, ophthalmologic, growth, behavioral, and other abnormalities were each present in a subset of patients. The newly associated features potentially resulting from 17q12 duplication include height and weight above the 95th percentile, cataracts, microphthalmia, coloboma, astigmatism, tracheomalacia, cutaneous mosaicism, pectus excavatum, scoliosis, hypermobility, hypospadias, diverticulum of Kommerell, pyloric stenosis, and pseudohypoparathryoidism. The majority of duplications were inherited with some carrier parents reporting learning disabilities or microcephaly. We identified additional, potentially contributory copy number changes in a subset of patients, including one patient each with 16p11.2 deletion and 15q13.3 deletion. Our data further define and expand the clinical spectrum associated with duplications of 17q12 and provide support for the role of genomic modifiers contributing to phenotypic variability. © 2015 Wiley Periodicals, Inc.
CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b−/− mice favoring autoimmune cholangitis
Concepcion, Axel R. , Salas, January T., Sáez, Elena , Sarvide, Sarai , Ferrer, Alex, Portu, Ainhoa, Uriarte, Iker , Hervás‐Stubbs, Sandra , Prìeto, Jesús , Ferrer, Alejandro , Ferrer, Alex, Elferink, Ronald P.J. Oude , Gallardo, Juan Francisco Medina , Ferrer, Alejandro , Hervás-Stubbs, Sandra

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 30 | Pages: 28588-28606

10.18632/oncotarget.5665 | PMID 26396175 Get It

HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Roy, Debarshi , Camacho-Pereira, Juliana , Khurana, Ashwani, Chini, Eduardo N. , Yang, Lifeng , Baddour, Joelle, Stilles, Katherine, Padmabandu, Seth, Leung, Sam, Lowe, Val J. , Dierks, Thomas , Hammond, Edward , Dredge, Keith , Nagrath, Deepak , Shridhar, Viji , Mondal, Susmita, Chini, Eduardo, Mondal, Susmita , Kalloger, Steve E. , Gilks, C. Blake

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 32 | Pages: 33705-33719

10.18632/oncotarget.5605 | PMID 26378042 Get It

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer
Patel, Manish R. , Jacobson, Blake A., Drees, Jeremy, Tang, Shaogeng , Xiong, Kerry, Wang, Hengbing , Prigge, Jennifer E., Dash, Alexander , Kratzke, Andrea K., Mesev, Emily V. , Etchison, Ryan, Federspiel, Mark J. , Russell, Stephen J. , Kratzke, Robert A. , Ji, Yan , Russell, Stephen J

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 32 | Pages: 33165-33177

10.18632/oncotarget.5320 | PMID 26431376 Get It

Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer
Kim, Yi Rang , Park, Mi Sung, Eum, Ki-Hwan, Kim, Juhee, Bae, Taejeong , Lee, Dae Ho , Choi, Jin Woo , Eum, Ki‐Hwan, Lee, Jeong Won , Bae, Taejeong

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 31 | Pages: 31030-31038

10.18632/oncotarget.5208 | PMID 26307679 Get It